DE69129238D1 - Okulare hypotensive homo-prostaglandinderivate - Google Patents
Okulare hypotensive homo-prostaglandinderivateInfo
- Publication number
- DE69129238D1 DE69129238D1 DE69129238T DE69129238T DE69129238D1 DE 69129238 D1 DE69129238 D1 DE 69129238D1 DE 69129238 T DE69129238 T DE 69129238T DE 69129238 T DE69129238 T DE 69129238T DE 69129238 D1 DE69129238 D1 DE 69129238D1
- Authority
- DE
- Germany
- Prior art keywords
- homo
- derivatives
- prostagland
- ocular hypotensive
- prostaglandin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62465990A | 1990-12-10 | 1990-12-10 | |
PCT/US1991/009288 WO1992010193A2 (en) | 1990-12-10 | 1991-12-05 | Homo-prostaglandin derivatives as ocular hypotensives |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69129238D1 true DE69129238D1 (de) | 1998-05-14 |
DE69129238T2 DE69129238T2 (de) | 1998-12-03 |
Family
ID=24502829
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69129238T Expired - Fee Related DE69129238T2 (de) | 1990-12-10 | 1991-12-05 | Okulare hypotensive homo-prostaglandinderivate |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0562006B1 (de) |
JP (1) | JPH06503345A (de) |
AT (1) | ATE164763T1 (de) |
AU (1) | AU654167B2 (de) |
BR (1) | BR9107162A (de) |
CA (1) | CA2096944A1 (de) |
DE (1) | DE69129238T2 (de) |
ES (1) | ES2113942T3 (de) |
HU (1) | HUT64305A (de) |
IE (1) | IE914261A1 (de) |
WO (1) | WO1992010193A2 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5011856A (en) * | 1990-03-12 | 1991-04-30 | Allergan, Inc. | Use of prostaglandin F3 α as an ocular hypotensive agent |
US5288754A (en) * | 1992-02-04 | 1994-02-22 | Allergan, Inc. | Polar C-1 esters of prostaglandins |
US6124353A (en) * | 1992-11-12 | 2000-09-26 | Allergan Sales, Inc. | Method of treating ocular hypertension with 8-epi prostaglandins |
KR950000664A (ko) * | 1993-06-14 | 1995-01-03 | 우에노 도시오 | 신규한 13,14-디히드로-피지에프 2 베타(PGF2β) 및 이의 이소프로필 에스테르 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1156465A (en) * | 1967-02-16 | 1969-06-25 | Unilever Ltd | Prostaglandins |
DE2118686A1 (de) * | 1970-04-20 | 1971-11-11 | The Upjohn Co., Kalamazoo, Mich. (V.StA.) | Prostaglandinverbindungen und Verfahren zu ihrer Herstellung |
US4254145A (en) * | 1978-08-16 | 1981-03-03 | American Cyanamid Company | Topical application of prostaglandin hypotensive agents |
US4824857A (en) * | 1986-05-16 | 1989-04-25 | Yasumasa Goh | Use of prostaglandin D2 -active substances |
ZA88963B (en) * | 1987-02-27 | 1989-11-29 | Allergan Inc | Prostaglandins useful for lowering intraocular pressure |
-
1991
- 1991-12-05 JP JP4502971A patent/JPH06503345A/ja active Pending
- 1991-12-05 ES ES92902760T patent/ES2113942T3/es not_active Expired - Lifetime
- 1991-12-05 WO PCT/US1991/009288 patent/WO1992010193A2/en active IP Right Grant
- 1991-12-05 CA CA002096944A patent/CA2096944A1/en not_active Abandoned
- 1991-12-05 DE DE69129238T patent/DE69129238T2/de not_active Expired - Fee Related
- 1991-12-05 EP EP92902760A patent/EP0562006B1/de not_active Expired - Lifetime
- 1991-12-05 BR BR9107162A patent/BR9107162A/pt not_active Application Discontinuation
- 1991-12-05 AT AT92902760T patent/ATE164763T1/de not_active IP Right Cessation
- 1991-12-05 HU HU9301364A patent/HUT64305A/hu unknown
- 1991-12-05 AU AU91482/91A patent/AU654167B2/en not_active Ceased
- 1991-12-09 IE IE426191A patent/IE914261A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HU9301364D0 (en) | 1993-09-28 |
WO1992010193A2 (en) | 1992-06-25 |
HUT64305A (en) | 1993-12-28 |
WO1992010193A3 (en) | 1992-10-29 |
IE914261A1 (en) | 1992-06-17 |
BR9107162A (pt) | 1994-06-21 |
ES2113942T3 (es) | 1998-05-16 |
AU654167B2 (en) | 1994-10-27 |
EP0562006A1 (de) | 1993-09-29 |
CA2096944A1 (en) | 1992-06-11 |
AU9148291A (en) | 1992-07-08 |
JPH06503345A (ja) | 1994-04-14 |
ATE164763T1 (de) | 1998-04-15 |
DE69129238T2 (de) | 1998-12-03 |
EP0562006B1 (de) | 1998-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2138691T3 (es) | Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina. | |
BG40964A3 (en) | Method for preparing 8- chlor- 1, 5- benzothiazepin derivatives | |
MX9102582A (es) | Derivados de indol 3,7-disubstituidos, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
ATE158506T1 (de) | Okulare hypotensive 2-dekarboxyl-2-aminoalkyl- prostaglandine | |
ES2071227T3 (es) | Composicion para gotas para los ojos. | |
SE8703854D0 (sv) | Prostaglandinderivat for behandling av glaukom eller okuler hypertension | |
NO930035D0 (no) | Eksitatoriske aminosyreantagonister | |
ES2079872T3 (es) | Derivados hipotensores oculares de la 2-descarboxil-2-aciltioalquilprostaglandina. | |
ES499299A0 (es) | Procedimiento de preparacion de derivados de la trimetoxi- 3,4,5 cinamoilpiperacina | |
DE69129238D1 (de) | Okulare hypotensive homo-prostaglandinderivate | |
CO5011066A1 (es) | Compuestos de triazina | |
FI892222A0 (fi) | Peptidalkoholer med antikoagulantverkan. | |
BG34610A3 (en) | Method for preparating 2', 6'- dialkyl- n- (alkoxymethyl)- 2- chloracetanylides | |
LV10098A (lv) | Metilpiperazinazepina atvasinajumi to iegusana un lietosana | |
DE69005006D1 (de) | 2,5,6,7-Tetranor-4,8-inter-m-phenylen-PGI2-Derivate. | |
ES2061481T3 (es) | Derivados de 3,4-dihidrobenzoazina opticamente activos y procedimiento para la preparacion de los mismos. | |
AR247200A1 (es) | Procedimiento para preparar una nueva clase de agentes medicinales piperidinilicos, utiles como agentes antitromboticos y como antagonistas de los receptores de 5ht2 de serotonina. | |
GR1001309B (el) | Μεθοδος παρασκευης παραγωγου ενωσεως της διχλωροανιλινης. | |
FI912382A (fi) | Menetelmä heterosyklisten NMDA-antagonistien valmistamiseksi | |
ES2082890T3 (es) | Procedimiento para la preparacion de derivados 6-(aminopropionilo sustituido) de forskolina. | |
ES2051953T3 (es) | Derivados isomeros de trimetilbiciclo(4,3,0)nonano. | |
SE8700566L (sv) | Tetracykliska kinazolinoner | |
NO921317D0 (no) | Antimetastatisk virkende midler | |
BE860603A (fr) | Derives de l'oxadiazole-1,2,4 utilisables comme azureurs optiques | |
ATE138574T1 (de) | Verwendung von prostaglandin f3alpha als okulares hypotensivum |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |